CATHERS BRIAN EDWIN

CIK 00017691271 companySOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001769127

Recent Transactions

26 trades

Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2021-03-01−3,750→ 15,000 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2021-03-01+17,733→ 17,733 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2021-03-01$44.48/sh−1,297→ 12,005 total
Award
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2021-03-01+31,082→ 31,082 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2021-03-01+3,750→ 13,302 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2021-02-01+3,020→ 10,730 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2021-02-01$49.49/sh−1,178→ 9,552 total
Award
Global Blood Therapeutics, Inc.
Common Stock
2021-02-01$41.17/sh+267→ 7,710 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2021-02-01−3,020→ 18,120 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2020-09-01$60.45/sh−1,551→ 7,443 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2020-09-01−3,750→ 18,750 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2020-09-01+3,750→ 8,994 total
Sale
Global Blood Therapeutics, Inc.
Common Stock
2020-08-20$63.77/sh−2,200→ 5,244 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2020-08-01+3,020→ 8,489 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2020-08-01$67.48/sh−1,045→ 7,444 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2020-08-01−3,020→ 21,140 total
Award
Global Blood Therapeutics, Inc.
Common Stock
2020-07-31$41.17/sh+290→ 5,469 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2020-06-01+42,400→ 42,400 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2020-03-01$63.96/sh−2,594→ 5,179 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2020-03-01+7,500→ 7,773 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2020-03-01−7,500→ 22,500 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2020-02-03+24,160→ 24,160 total
Award
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2020-02-03+38,500→ 38,500 total
Award
Global Blood Therapeutics, Inc.
Common Stock
2020-01-31$41.17/sh+273→ 273 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2019-03-01+30,000→ 30,000 total
Award
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2019-03-01+45,000→ 45,000 total

Companies

Global Blood Therapeutics, Inc.
See Remarks

Recent Filings

Address

C/O GLOBAL BLOOD THERAPEUTICS, INC. 171 OYSTER POINT BLVD., SUITE 300

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov